Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

NCT04354324 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Papillary Thyroid Cancer

Interventions

DRUG: Radioiodine

Sponsor

Zhujiang Hospital